Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now

'Stay with quality' holds true for equity and debt schemes; 16 funds worth considering

Brokerage firm Sharekhan has listed 16 debt fund which are high-quality short duration and corporate bond category schemes.

April 27, 2020 / 10:05 AM IST

If you are an equity investor, you might have heard experts often citing "quality" as the basis of investments. But what about debt funds? Does the same rule apply to them as well? Answer: YES!

Most of the equity investors’ portfolios are down by over 30 percent thanks to persistent selling by foreign investors, over a month-long lockdown that has halted economic activity and a shutdown of plants across India and globe which could have major implications on June and September quarterly earnings.

In short, stock prices across the board have taken a beating. Liquidity is not an issue with largecap names but could be a concern in stocks that remain fairly illiquid that are mostly small or midcaps.

A similar problem of liquidity hit Franklin Templeton AMC which decided to wind up 6 of its fixed-income funds which had a collective AUM of nearly Rs 30,000 crore. The decision to wind up schemes has shaken the debt MF industry.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Experts feel that sticking to "Quality" is what will get you through tough times, and advised investing in funds or schemes that do not take excessive risks.

“The decision by Franklin Templeton to voluntarily wind up six of their debt funds has shaken up the debt mutual fund industry. This coming after a series of NAV write-downs/segregation by various fund houses due to downgrades/defaults by investee companies will not do any good for the risk-on sentiments of retail and HNI investors,” Deepak Jasani, Head Of Research, HDFC Securities told Moneycontrol.

“This episode once again highlights the weakness in the secondary debt markets in India as they tend to get illiquid by small bouts of micro and macro negative news. Despite the categorisation by SEBI, a lot of debt schemes take on risks that are not reflected in their scheme's risk-o-meter or their category names,” he said.

Fund managers with a view of generating higher returns, tend to take higher risks in the portion of other investments permitted in even safe low-risk categories, say experts. In crisis situations, any portfolio with exposure to credit risk debt instruments have a risk of liquidity and will be adversely impacted.

COVID-19 turned out to be the worst nightmare for equity as well as debt fund investors. At a time when most of the economists are factoring in a near-zero growth rate for the economy – stocks, as well as debt funds, will take a hit or face redemption pressure as investors try and raise cash.

Franklin Templeton was not able to funds these redemptions and therefore winded up 6 schemes under redemption pressure, now as and when the money is realised the same will be credited to the unitholders.

“Debt funds are dominated by corporates and HNIs from the investment side and most of the corporates due to COVID-19 lockdown have liquidity issues and are therefore aggressively redeeming debt mutual funds to meet cash requirements,” Omkeshwar Singh, Head- RankMF, Samco Securities told Moneycontrol.

“Retail Investors should be Prudent while investing in debt funds and should always look ONLY for the quality of the portfolio and should completely ignore past performance, big names and big brands while making investments,” he said.

Another brokerage firm, Sharekhan, in a note, advised investors to be safe rather than sorry, and adopt a conservative approach. Such unprecedented incidents underline the advantage of adopting a conservative approach to invest in fixed income products.

“The philosophy is followed rigorously by us in terms of focus on the quality of paper and exposure to troubled sectors,” it said.

Sharekhan has listed 16 debt funds that are high-quality short duration and corporate bond category schemes. Also, investors with a short-term tenure should prefer liquid category schemes than arbitrage schemes given the current market scenario, the brokerage added.

Sharekhan April 25

Disclaimer: The views and investment tips expressed by investment experts on are their own and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Kshitij Anand is the Editor Markets at Moneycontrol.
ISO 27001 - BSI Assurance Mark